FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022795082> ?p ?o ?g. }

• W2022795082 endingPage "300" @default.
• W2022795082 startingPage "295" @default.
• W2022795082 abstract "To investigate the influence of the interfraction interval (IFI) on treatment outcome and toxicity in hyperfractionated (HF) radiotherapy (RT) for Stage III non-small-cell lung cancer.Data for 301 patients treated with 1.2 Gy b.i.d. to a total of 69.6 Gy and concurrent chemotherapy in our 3 prospective studies were analyzed. The chemotherapy regimen was either (1) 50 mg each of carboplatin and etoposide (CE) given on RT days (163 patients) or (2) 30 mg of CE on RT days and 100 mg of CE on Saturdays and Sundays during the RT course (138 patients). An IFI of 4.5-5 h or 5.5-6 h had been nonrandomly assigned for each patient, and this interval was kept throughout the treatment.No difference was observed in treatment outcome due to the chemotherapy protocol, and the 2 groups were combined. Patients treated with the shorter IFI had a better local control rate (38% at 5 years) and survival rate (30% at 5 years) than those treated with the longer interval (23% and 14%, respectively; p < 0.001). However, female patients and those with a high Karnofsky performance status score (KPS), weight loss of < or =5% in the previous 6 months, or Stage IIIA disease had been more often treated with the shorter IFI, and these characteristics were associated with better treatment outcome. In multivariate analysis, only gender, KPS, and weight change proved to be significant prognostic factors influencing both local control and survival, and the effect of IFI was not significant. The incidence of Grade 4 acute esophagitis tended to be higher in the shorter interval group (p = 0.072), but there were no differences in the incidence of late or other acute RT-related toxicities between the 2 groups.The possible influence of the IFI on local control and survival could not be verified using multivariate analysis. To better understand the influence of the IFI, randomized studies with more patients and wider ranges of intervals (e.g., 5 h vs. 8 h) seem to be necessary." @default.
• W2022795082 created "2016-06-24" @default.
• W2022795082 creator A5005949003 @default.
• W2022795082 creator A5042791820 @default.
• W2022795082 creator A5058609591 @default.
• W2022795082 creator A5071240286 @default.
• W2022795082 creator A5084712059 @default.
• W2022795082 date "2001-06-01" @default.
• W2022795082 modified "2023-10-16" @default.
• W2022795082 title "Influence of interfraction interval on the efficacy and toxicity of hyperfractionated radiotherapy in combination with concurrent daily chemotherapy in Stage III non–small-cell lung cancer" @default.
• W2022795082 cites W1883860222 @default.
• W2022795082 cites W1930978022 @default.
• W2022795082 cites W1981043389 @default.
• W2022795082 cites W1982035381 @default.
• W2022795082 cites W1994194666 @default.
• W2022795082 cites W2011289165 @default.
• W2022795082 cites W2026336655 @default.
• W2022795082 cites W2043945205 @default.
• W2022795082 cites W2052182568 @default.
• W2022795082 cites W2054385160 @default.
• W2022795082 cites W2065333550 @default.
• W2022795082 cites W2075946022 @default.
• W2022795082 cites W2077668530 @default.
• W2022795082 cites W2086205241 @default.
• W2022795082 cites W2094968702 @default.
• W2022795082 cites W2097315335 @default.
• W2022795082 cites W2105148745 @default.
• W2022795082 cites W2108215214 @default.
• W2022795082 cites W2117072480 @default.
• W2022795082 cites W2133555954 @default.
• W2022795082 cites W2145703501 @default.
• W2022795082 cites W2151415400 @default.
• W2022795082 doi "https://doi.org/10.1016/s0360-3016(01)01440-7" @default.
• W2022795082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11380214" @default.
• W2022795082 hasPublicationYear "2001" @default.
• W2022795082 type Work @default.
• W2022795082 sameAs 2022795082 @default.
• W2022795082 citedByCount "6" @default.
• W2022795082 countsByYear W20227950822021 @default.
• W2022795082 crossrefType "journal-article" @default.
• W2022795082 hasAuthorship W2022795082A5005949003 @default.
• W2022795082 hasAuthorship W2022795082A5042791820 @default.
• W2022795082 hasAuthorship W2022795082A5058609591 @default.
• W2022795082 hasAuthorship W2022795082A5071240286 @default.
• W2022795082 hasAuthorship W2022795082A5084712059 @default.
• W2022795082 hasConcept C121608353 @default.
• W2022795082 hasConcept C126322002 @default.
• W2022795082 hasConcept C141071460 @default.
• W2022795082 hasConcept C143998085 @default.
• W2022795082 hasConcept C146357865 @default.
• W2022795082 hasConcept C151730666 @default.
• W2022795082 hasConcept C155806632 @default.
• W2022795082 hasConcept C2776256026 @default.
• W2022795082 hasConcept C2776694085 @default.
• W2022795082 hasConcept C2776907518 @default.
• W2022795082 hasConcept C2778119113 @default.
• W2022795082 hasConcept C2778239845 @default.
• W2022795082 hasConcept C2781413609 @default.
• W2022795082 hasConcept C2781451048 @default.
• W2022795082 hasConcept C2908786992 @default.
• W2022795082 hasConcept C29730261 @default.
• W2022795082 hasConcept C509974204 @default.
• W2022795082 hasConcept C71924100 @default.
• W2022795082 hasConcept C86803240 @default.
• W2022795082 hasConcept C90924648 @default.
• W2022795082 hasConceptScore W2022795082C121608353 @default.
• W2022795082 hasConceptScore W2022795082C126322002 @default.
• W2022795082 hasConceptScore W2022795082C141071460 @default.
• W2022795082 hasConceptScore W2022795082C143998085 @default.
• W2022795082 hasConceptScore W2022795082C146357865 @default.
• W2022795082 hasConceptScore W2022795082C151730666 @default.
• W2022795082 hasConceptScore W2022795082C155806632 @default.
• W2022795082 hasConceptScore W2022795082C2776256026 @default.
• W2022795082 hasConceptScore W2022795082C2776694085 @default.
• W2022795082 hasConceptScore W2022795082C2776907518 @default.
• W2022795082 hasConceptScore W2022795082C2778119113 @default.
• W2022795082 hasConceptScore W2022795082C2778239845 @default.
• W2022795082 hasConceptScore W2022795082C2781413609 @default.
• W2022795082 hasConceptScore W2022795082C2781451048 @default.
• W2022795082 hasConceptScore W2022795082C2908786992 @default.
• W2022795082 hasConceptScore W2022795082C29730261 @default.
• W2022795082 hasConceptScore W2022795082C509974204 @default.
• W2022795082 hasConceptScore W2022795082C71924100 @default.
• W2022795082 hasConceptScore W2022795082C86803240 @default.
• W2022795082 hasConceptScore W2022795082C90924648 @default.
• W2022795082 hasFunder F4320320912 @default.
• W2022795082 hasIssue "2" @default.
• W2022795082 hasLocation W20227950821 @default.
• W2022795082 hasLocation W20227950822 @default.
• W2022795082 hasOpenAccess W2022795082 @default.
• W2022795082 hasPrimaryLocation W20227950821 @default.
• W2022795082 hasRelatedWork W1989051367 @default.
• W2022795082 hasRelatedWork W2013653877 @default.
• W2022795082 hasRelatedWork W2029688276 @default.
• W2022795082 hasRelatedWork W2140411476 @default.
• W2022795082 hasRelatedWork W2238661971 @default.
• W2022795082 hasRelatedWork W2348495938 @default.
• W2022795082 hasRelatedWork W2359366932 @default.

• next